AYTU Company Profile and Key Details

Q: Who are the executives of AYTU?

Mr. Christopher BrookeChief Operating OfficerMs. Victoria CordovaVice President of People & CultureMr. Jarrett T. Disbrow Ph.D.Chief Bus. Officer & Pres of Consumer HealthMr. Russ McMahenSenior Vice President of R&DMr. Ryan J. Selhorn CPAExecutive Vice President of Fin. & Bus. OptimizationMr. Greg PyszczymukaChief Commercial OfficerMr. Topher BrookeChief Operating OfficerMr. Joshua R. DisbrowChairman & Chief Executive OfficerMr. Mark K. Oki CPAChief Financial Officer, Sec. & Treasurer

NASDAQ : AYTU

Aytu BioPharma

$2.29

0.05+2.23%

At Close 4:00 PM

59.8

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Aytu BioPharma, Inc. (AYTU) stock surged +2.23%, trading at $2.29 on NASDAQ, up from the previous close of $2.24. The stock opened at $2.27, fluctuating between $2.23 and $2.31 in the recent session.

Stock Snapshot

2.24

Prev. Close

18.55M

Market Cap

2.23

Day Low

-0.5

P/E Ratio

-4.61

EPS (TTM)

1.11

Cash Flow per Share

2.27

Open

8.1M

Number of Shares

2.31

Day High

100.13%

Free Float in %

5.95

Book Value

46.83K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 29, 2026	2.23	2.31	2.19	2.29	46.83K
May 28, 2026	2.23	2.25	2.17	2.24	10.14K
May 27, 2026	2.16	2.22	2.13	2.21	24.39K
May 26, 2026	2.17	2.19	2.11	2.18	40.1K
May 22, 2026	2.13	2.19	2.12	2.19	20.56K
May 21, 2026	2.12	2.16	2.07	2.13	27.74K
May 20, 2026	2.11	2.15	2.03	2.15	29.46K
May 19, 2026	2.12	2.14	1.98	2.08	119.46K
May 18, 2026	2.19	2.19	2.02	2.10	105.48K
May 15, 2026	2.27	2.27	2.17	2.19	75.94K
May 14, 2026	2.33	2.34	2.22	2.27	71.47K
May 13, 2026	2.30	2.31	2.23	2.25	100.08K
May 12, 2026	2.45	2.47	2.20	2.30	119.94K
May 11, 2026	2.51	2.55	2.43	2.44	99.22K
May 08, 2026	2.49	2.54	2.49	2.50	7.73K
May 07, 2026	2.58	2.58	2.47	2.47	94.58K
May 06, 2026	2.55	2.56	2.52	2.56	17.34K
May 05, 2026	2.55	2.62	2.55	2.57	17.58K
May 04, 2026	2.58	2.63	2.52	2.55	84.8K
Apr 30, 2026	2.47	2.58	2.47	2.58	25.3K

Contact Details

Englewood, CO 80112

United States

https://aytubio.com 720 437 6580

About Company

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.

Stock Peers

NBIX

1.91+1.22%

Neurocrine Biosciences, Inc.$158.30 ITCI

Intra-Cellular Therapies, Inc.$131.87 LNTH

-0.32-0.32%

Lantheus Holdings, Inc.$99.30 ANIP

-2.6-3.21%

ANI Pharmaceuticals, Inc.$78.51 SUPN

-0.67-1.43%

Supernus Pharmaceuticals, Inc.$46.18 INDV

-0.59-1.61%

Indivior Pharmaceuticals Inc$36.02 HROW

-0.18-0.51%

Harrow Health, Inc.$35.21 COLL

0.24+0.72%

Collegium Pharmaceutical, Inc.$33.61 PETQ

-0.01-0.03%

PetIQ, Inc.$30.98 PAHC

-1.04-3.27%

Phibro Animal Health Corporation$30.79

Frequently Asked Questions

What is the current Aytu BioPharma, Inc. (AYTU) stock price?

Aytu BioPharma, Inc. (NASDAQ: AYTU) stock price is $2.29 in the last trading session. During the trading session, AYTU stock reached the peak price of $2.31 while $2.23 was the lowest point it dropped to. The percentage change in AYTU stock occurred in the recent session was 2.23% while the dollar amount for the price change in AYTU stock was $0.05.

AYTU's industry and sector of operation?

The NASDAQ listed AYTU is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Aytu BioPharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AYTU?

Mr. Christopher Brooke
Chief Operating Officer
Ms. Victoria Cordova
Vice President of People & Culture
Mr. Jarrett T. Disbrow Ph.D.
Chief Bus. Officer & Pres of Consumer Health
Mr. Russ McMahen
Senior Vice President of R&D
Mr. Ryan J. Selhorn CPA
Executive Vice President of Fin. & Bus. Optimization
Mr. Greg Pyszczymuka
Chief Commercial Officer
Mr. Topher Brooke
Chief Operating Officer
Mr. Joshua R. Disbrow
Chairman & Chief Executive Officer
Mr. Mark K. Oki CPA
Chief Financial Officer, Sec. & Treasurer

How AYTU did perform over past 52-week?

AYTU's closing price is 56.85% higher than its 52-week low of $1.46 where as its distance from 52-week high of $3.07 is -25.41%.

How many employees does AYTU have?

Number of AYTU employees currently stands at 102.

Link for AYTU official website?

Official Website of AYTU is: https://aytubio.com

How do I contact AYTU?

AYTU could be contacted at phone 720 437 6580 and can also be accessed through its website. AYTU operates from 373 Inverness Parkway, Englewood, CO 80112, United States.

How many shares of AYTU are traded daily?

AYTU stock volume for the day was 46.83K shares. The average number of AYTU shares traded daily for last 3 months was 45.21K.

What is the market cap of AYTU currently?

The market value of AYTU currently stands at $18.55M with its latest stock price at $2.29 and 8.1M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	102
Beta	0.34
Sales or Revenue	$66.38M
5Y Sales Change%	-0.912%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Employees	102
Beta	0.34
Sales or Revenue	$66.38M
5Y Sales Change%	-0.912%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

AYTU Company Profile and Key Details

Aytu BioPharma

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Valuation Metrics

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways